Tobacco Cessation in Bharuch — Samarth Chest Hospital & ICU

About this service

Structured Post-COVID Lung Care for patients with persistent cough, breathlessness, low oxygen, fibrosis on HRCT or reduced exercise tolerance after COVID-19.

Baseline PFT, 6MWT and HRCT review
Personalised pulmonary rehabilitation plan
Home oxygen guidance when needed
Mental-health and sleep screening

About Tobacco Cessation Clinic at Samarth Chest Hospital, Bharuch

Quitting tobacco is the single most effective step for lung, heart and cancer health. Our tobacco cessation clinic combines behavioural counselling, nicotine-replacement therapy (patch, gum, lozenge), bupropion or varenicline where indicated, and structured relapse-prevention follow-up over the first 6–12 months.

Who typically needs this

Current smokers or bidi users of any age
Long-term chewable-tobacco / gutkha users
Patients with COPD, asthma, TB, cardiac or pre-cancer diagnosis
Pregnancy or planning pregnancy
Anyone whose family wants them to quit

How to prepare

List daily quantity, brand and time of first use each day
Note previous quit attempts and what worked/failed
Bring records of any COPD, cardiac or oral pre-cancer diagnosis

What to expect

Fagerstrom nicotine-dependence scoring
Personalised quit-date and taper plan
Prescription of NRT, bupropion or varenicline where indicated
Behavioural strategies for cravings, triggers and relapse
Structured follow-ups at 1, 2, 4, 8 and 12 weeks

After the visit

Written 12-week quit plan
Family involvement encouraged
Long-term relapse-prevention check-ins
Onward oral-pathology or cardiology referral if indicated

Why patients in Bharuch choose Samarth Chest Hospital

Evidence-based combination therapy
Non-judgemental counselling
Structured follow-up, not one-off advice
Care coordinated with the treating pulmonologist

Frequently asked questions

How successful are quit programmes?

With structured counselling and pharmacotherapy, 6-month abstinence rates are 4–6× higher than 'willpower alone' quit attempts.

Is NRT safe?

Yes — nicotine replacement therapy is far safer than continued smoking. Patch/gum/lozenge are chosen based on your usage pattern and preference.

What about e-cigarettes and vaping?

E-cigarettes are not a recommended cessation tool in India and carry their own respiratory risks. Approved therapies (NRT, bupropion, varenicline) remain first-line.

How long is follow-up?

Structured touchpoints at 1, 2, 4, 8 and 12 weeks, with longer-term check-ins at 6 and 12 months for relapse prevention.

Can chewable-tobacco / gutkha users be helped?

Yes — the same behavioural and pharmacological framework applies, along with oral-cavity screening for pre-cancer lesions.

The information above is educational and does not replace an in-person consultation. For a personalised plan, book with Dr Saurabh Bhatt (MD Pulmonology) at Samarth Chest Hospital & ICU, 4th Floor, RK Casta, Bharuch — call +91 90161 12968 or WhatsApp us.